Duchenne Muscular Dystrophy Models Show Their Age

The lack of appropriate animal models has hampered efforts to develop therapies for Duchenne muscular dystrophy (DMD). A new mouse model lacking both dystrophin and telomerase () closely mimics the pathological progression of human DMD and shows that muscle stem cell activity is a key determinant of disease severity.